Nanobac Pharmaceuticals, Incorporated
NNBP · OTC
12/31/2007 | 12/31/2006 | 12/31/2005 | 12/31/2004 | |
|---|---|---|---|---|
| Market Cap | $12 | $24 | $7 | $22 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $4 | $5 | $2 | $0 |
| Enterprise Value | $16 | $29 | $9 | $22 |
| Revenue | $0 | $0 | $1 | $0 |
| % Growth | -92.2% | -65.7% | 83.3% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 17.6% | 64.5% | 65.1% | 72% |
| EBITDA | -$6 | -$4 | -$3 | -$7 |
| % Margin | -33,646.8% | -1,880.6% | -434.9% | -1,920.8% |
| Net Income | -$7 | -$5 | -$4 | -$8 |
| % Margin | -37,319.7% | -2,209.5% | -561.4% | -2,197.4% |
| EPS Diluted | 0 | -0.025 | -0.02 | -0.052 |
| % Growth | 100% | -27.7% | 62.1% | – |
| Operating Cash Flow | -$1 | -$3 | -$2 | -$3 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$1 | -$3 | -$2 | -$3 |